Methods for the treatment of alcohol abuse, addiction and dependency

Details for Australian Patent Application No. 2007325365 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Vaidya, Anil

Agent Shelston IP

Pub. Number AU-A-2007325365

PCT Pub. Number WO2008/067177

Priority 60/861,375 28.11.06 US

Filing date 15 November 2007

Wipo publication date 5 June 2008

International Classifications

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61P 25/32 (2006.01) Drugs for disorders of the nervous system

Event Publications

11 June 2009 PCT application entered the National Phase

  PCT publication WO2008/067177 Priority application(s): WO2008/067177

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007325387-Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders

2007325355-Salts of 3-(3-amino-2-(R)-hydroxy-propyl)-1-(4-fl uoro- phenyl)-8-(8-methyl-naphthalen-1-ylmet hyl)-1,3,8-triaza-spiro[4.5]decan-4-one